Allergen reduction by nightly temperature controlled laminar airflow (TLA) decreases exacerbation rate in severe allergic asthma

Uwe Schauer,Eckard Hamelmann

doi:10.1186/2045-7022-5-s2-o5

Uwe Schauer, Eckard Hamelmann

Open Access

https://doi.org/10.1186/2045-7022-5-s2-o5

Copy DOI

Abstract

It has earlier been shown that TLA significantly reduces allergen exposure and airway inflammation and improves quality of life in poorly controlled allergic asthma patients.

Highlights

It has earlier been shown that temperature controlled laminar airflow (TLA) significantly reduces allergen exposure and airway inflammation and improves quality of life in poorly controlled allergic asthma patients
It has earlier been shown that TLA significantly reduces allergen exposure and airway inflammation and improves quality of life in poorly controlled allergic asthma patients
The data demonstrate that TLA may be an important new approach in the treatment of poorly controlled allergic asthma patients

Summary

Introduction

It has earlier been shown that TLA significantly reduces allergen exposure and airway inflammation and improves quality of life in poorly controlled allergic asthma patients. Aim and objective The primary aim was to evaluate real-life effects of TLA (Airsonett AB) when used during night-time for 12 consecutive months as add on to the patients’ regular medication

Methods

Results

Conclusion